

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.60202654 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.60202654 |
| 3 | aromatic amino acid family catabolic process (GO:0009074) | 4.44103001 |
| 4 | tryptophan catabolic process (GO:0006569) | 4.38238545 |
| 5 | indole-containing compound catabolic process (GO:0042436) | 4.38238545 |
| 6 | indolalkylamine catabolic process (GO:0046218) | 4.38238545 |
| 7 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.36658538 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 4.33987053 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.33987053 |
| 10 | fatty acid beta-oxidation (GO:0006635) | 4.25910224 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.25704721 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.25704721 |
| 13 | tryptophan metabolic process (GO:0006568) | 4.24965388 |
| 14 | kynurenine metabolic process (GO:0070189) | 3.97967145 |
| 15 | glyoxylate metabolic process (GO:0046487) | 3.96351930 |
| 16 | amino-acid betaine metabolic process (GO:0006577) | 3.95249278 |
| 17 | fatty acid catabolic process (GO:0009062) | 3.91695465 |
| 18 | carnitine metabolic process (GO:0009437) | 3.91632404 |
| 19 | fatty acid oxidation (GO:0019395) | 3.84382892 |
| 20 | negative T cell selection (GO:0043383) | 3.79543470 |
| 21 | lipid oxidation (GO:0034440) | 3.79099934 |
| 22 | peptidyl-histidine modification (GO:0018202) | 3.77748800 |
| 23 | lysine catabolic process (GO:0006554) | 3.75512190 |
| 24 | lysine metabolic process (GO:0006553) | 3.75512190 |
| 25 | negative regulation of T cell mediated immunity (GO:0002710) | 3.71141855 |
| 26 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.69675179 |
| 27 | negative thymic T cell selection (GO:0045060) | 3.66384945 |
| 28 | histone H3-K4 trimethylation (GO:0080182) | 3.65356988 |
| 29 | bile acid biosynthetic process (GO:0006699) | 3.57248202 |
| 30 | monocarboxylic acid catabolic process (GO:0072329) | 3.56802256 |
| 31 | positive regulation of granulocyte differentiation (GO:0030854) | 3.53153110 |
| 32 | hepatocyte apoptotic process (GO:0097284) | 3.52771141 |
| 33 | fatty acid transmembrane transport (GO:1902001) | 3.51129579 |
| 34 | ubiquinone biosynthetic process (GO:0006744) | 3.51096673 |
| 35 | spindle assembly involved in mitosis (GO:0090307) | 3.51072396 |
| 36 | carnitine shuttle (GO:0006853) | 3.49242188 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 3.49194398 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 3.46453702 |
| 39 | short-chain fatty acid metabolic process (GO:0046459) | 3.45468770 |
| 40 | alpha-linolenic acid metabolic process (GO:0036109) | 3.41561178 |
| 41 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.41447302 |
| 42 | phospholipid homeostasis (GO:0055091) | 3.38199871 |
| 43 | branched-chain amino acid catabolic process (GO:0009083) | 3.37624440 |
| 44 | valine metabolic process (GO:0006573) | 3.35466710 |
| 45 | indolalkylamine metabolic process (GO:0006586) | 3.31108792 |
| 46 | 2-oxoglutarate metabolic process (GO:0006103) | 3.29901562 |
| 47 | amine catabolic process (GO:0009310) | 3.29640943 |
| 48 | cellular biogenic amine catabolic process (GO:0042402) | 3.29640943 |
| 49 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.28752695 |
| 50 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.24090468 |
| 51 | homocysteine metabolic process (GO:0050667) | 3.22529087 |
| 52 | branched-chain amino acid metabolic process (GO:0009081) | 3.22309077 |
| 53 | tolerance induction (GO:0002507) | 3.19721385 |
| 54 | regulation of memory T cell differentiation (GO:0043380) | 3.18671737 |
| 55 | replication fork processing (GO:0031297) | 3.17370688 |
| 56 | aromatic amino acid family metabolic process (GO:0009072) | 3.15978414 |
| 57 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.15959494 |
| 58 | phospholipid efflux (GO:0033700) | 3.14150131 |
| 59 | reverse cholesterol transport (GO:0043691) | 3.13547210 |
| 60 | urea metabolic process (GO:0019627) | 3.10543659 |
| 61 | urea cycle (GO:0000050) | 3.10543659 |
| 62 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.10239654 |
| 63 | protein-lipid complex remodeling (GO:0034368) | 3.10100434 |
| 64 | macromolecular complex remodeling (GO:0034367) | 3.10100434 |
| 65 | plasma lipoprotein particle remodeling (GO:0034369) | 3.10100434 |
| 66 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.06593757 |
| 67 | mitochondrial RNA metabolic process (GO:0000959) | 3.05741501 |
| 68 | blood coagulation, intrinsic pathway (GO:0007597) | 3.04738605 |
| 69 | fucose catabolic process (GO:0019317) | 3.04452616 |
| 70 | L-fucose metabolic process (GO:0042354) | 3.04452616 |
| 71 | L-fucose catabolic process (GO:0042355) | 3.04452616 |
| 72 | benzene-containing compound metabolic process (GO:0042537) | 3.02658860 |
| 73 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 3.01614610 |
| 74 | ubiquinone metabolic process (GO:0006743) | 3.01478920 |
| 75 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01297931 |
| 76 | NAD biosynthetic process (GO:0009435) | 3.00601107 |
| 77 | oxaloacetate metabolic process (GO:0006107) | 3.00491868 |
| 78 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.99968178 |
| 79 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.99535704 |
| 80 | bile acid metabolic process (GO:0008206) | 2.98638114 |
| 81 | peptidyl-lysine trimethylation (GO:0018023) | 2.98354910 |
| 82 | sulfur amino acid catabolic process (GO:0000098) | 2.98341496 |
| 83 | behavioral response to nicotine (GO:0035095) | 2.98248986 |
| 84 | activated T cell proliferation (GO:0050798) | 2.97858041 |
| 85 | acylglycerol homeostasis (GO:0055090) | 2.97422772 |
| 86 | triglyceride homeostasis (GO:0070328) | 2.97422772 |
| 87 | ethanol oxidation (GO:0006069) | 2.97328632 |
| 88 | drug transmembrane transport (GO:0006855) | 2.96173655 |
| 89 | viral mRNA export from host cell nucleus (GO:0046784) | 2.95766869 |
| 90 | carboxylic acid catabolic process (GO:0046395) | 2.93690378 |
| 91 | organic acid catabolic process (GO:0016054) | 2.93690378 |
| 92 | regulation of sequestering of triglyceride (GO:0010889) | 2.93689602 |
| 93 | coenzyme catabolic process (GO:0009109) | 2.93607092 |
| 94 | protein K11-linked deubiquitination (GO:0035871) | 2.92644605 |
| 95 | tRNA modification (GO:0006400) | 2.92605148 |
| 96 | complement activation, alternative pathway (GO:0006957) | 2.91858112 |
| 97 | tyrosine metabolic process (GO:0006570) | 2.91517817 |
| 98 | regulation of gamma-delta T cell activation (GO:0046643) | 2.91088102 |
| 99 | alpha-amino acid catabolic process (GO:1901606) | 2.89828841 |
| 100 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.88738121 |
| 101 | protein carboxylation (GO:0018214) | 2.88738121 |
| 102 | reciprocal DNA recombination (GO:0035825) | 2.88332961 |
| 103 | reciprocal meiotic recombination (GO:0007131) | 2.88332961 |
| 104 | carnitine transmembrane transport (GO:1902603) | 2.85959621 |
| 105 | cellular ketone body metabolic process (GO:0046950) | 2.84178905 |
| 106 | snRNA transcription (GO:0009301) | 2.83667547 |
| 107 | tricarboxylic acid cycle (GO:0006099) | 2.82206275 |
| 108 | thymic T cell selection (GO:0045061) | 2.80254432 |
| 109 | response to interleukin-15 (GO:0070672) | 2.79605446 |
| 110 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.78977875 |
| 111 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.78977875 |
| 112 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.78820395 |
| 113 | cysteine metabolic process (GO:0006534) | 2.78157065 |
| 114 | establishment of protein localization to Golgi (GO:0072600) | 2.78001801 |
| 115 | regulation of bile acid biosynthetic process (GO:0070857) | 2.77709639 |
| 116 | biotin metabolic process (GO:0006768) | 2.77337263 |
| 117 | negative regulation of lipase activity (GO:0060192) | 2.77227702 |
| 118 | amino-acid betaine transport (GO:0015838) | 2.76774487 |
| 119 | carnitine transport (GO:0015879) | 2.76774487 |
| 120 | nitrogen cycle metabolic process (GO:0071941) | 2.76621183 |
| 121 | low-density lipoprotein particle remodeling (GO:0034374) | 2.76139583 |
| 122 | T-helper cell differentiation (GO:0042093) | 2.75742092 |
| 123 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.75742092 |
| 124 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.75527997 |
| 125 | regulation of centriole replication (GO:0046599) | 2.74649050 |
| 126 | positive regulation of lipid catabolic process (GO:0050996) | 2.74596158 |
| 127 | acetyl-CoA metabolic process (GO:0006084) | 2.74104764 |
| 128 | epithelial cilium movement (GO:0003351) | 2.73572802 |
| 129 | rRNA catabolic process (GO:0016075) | 2.73425604 |
| 130 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.72058385 |
| 131 | positive regulation of fatty acid oxidation (GO:0046321) | 2.71393273 |
| 132 | xenobiotic catabolic process (GO:0042178) | 2.71072620 |
| 133 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.70564176 |
| 134 | cellular glucuronidation (GO:0052695) | 2.70279980 |
| 135 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.70225261 |
| 136 | cellular amino acid catabolic process (GO:0009063) | 2.69708001 |
| 137 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.69297096 |
| 138 | flavonoid metabolic process (GO:0009812) | 2.69295654 |
| 139 | alpha-beta T cell differentiation (GO:0046632) | 2.68797826 |
| 140 | T cell selection (GO:0045058) | 2.68152366 |
| 141 | response to nitrosative stress (GO:0051409) | 2.68007585 |
| 142 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.67477638 |
| 143 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.67477638 |
| 144 | cellular response to interleukin-15 (GO:0071350) | 2.67351659 |
| 145 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.66362478 |
| 146 | regulation of protein activation cascade (GO:2000257) | 2.65141899 |
| 147 | regulation of cholesterol esterification (GO:0010872) | 2.64535172 |
| 148 | regulation of sarcomere organization (GO:0060297) | 2.63299986 |
| 149 | regulation of cholesterol metabolic process (GO:0090181) | 2.63173792 |
| 150 | aspartate family amino acid catabolic process (GO:0009068) | 2.62808136 |
| 151 | replicative senescence (GO:0090399) | 2.62670986 |
| 152 | interkinetic nuclear migration (GO:0022027) | 2.62398670 |
| 153 | quinone biosynthetic process (GO:1901663) | 2.61837986 |
| 154 | NAD metabolic process (GO:0019674) | 2.61196462 |
| 155 | cofactor catabolic process (GO:0051187) | 2.61026885 |
| 156 | tricarboxylic acid metabolic process (GO:0072350) | 2.59604589 |
| 157 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.58785906 |
| 158 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.58139869 |
| 159 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.58139869 |
| 160 | histone H3-K4 methylation (GO:0051568) | 2.58117855 |
| 161 | axoneme assembly (GO:0035082) | 2.56663106 |
| 162 | T cell differentiation involved in immune response (GO:0002292) | 2.56599611 |
| 163 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.56599611 |
| 164 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.56599611 |
| 165 | DNA deamination (GO:0045006) | 2.55046416 |
| 166 | regulation of interleukin-5 production (GO:0032674) | 2.54505837 |
| 167 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.54138530 |
| 168 | peptidyl-lysine methylation (GO:0018022) | 2.51806307 |
| 169 | alpha-beta T cell activation (GO:0046631) | 2.49433353 |
| 170 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.47268200 |
| 171 | mRNA cleavage (GO:0006379) | 2.45665377 |
| 172 | protein targeting to Golgi (GO:0000042) | 2.45476846 |
| 173 | negative regulation of adaptive immune response (GO:0002820) | 2.44713823 |
| 174 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.44524783 |
| 175 | regulation of histone H3-K4 methylation (GO:0051569) | 2.43853017 |
| 176 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.43781405 |
| 177 | regulation of defense response to virus by host (GO:0050691) | 2.42848613 |
| 178 | positive regulation of defense response to virus by host (GO:0002230) | 2.42050042 |
| 179 | regulation of regulatory T cell differentiation (GO:0045589) | 2.41692576 |
| 180 | centriole replication (GO:0007099) | 2.41372907 |
| 181 | cardiovascular system development (GO:0072358) | 2.41067801 |
| 182 | maintenance of protein location in nucleus (GO:0051457) | 2.40992542 |
| 183 | protein K63-linked deubiquitination (GO:0070536) | 2.39867508 |
| 184 | * tRNA processing (GO:0008033) | 2.39137262 |
| 185 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.38283723 |
| 186 | recombinational repair (GO:0000725) | 2.37521160 |
| 187 | protein K48-linked deubiquitination (GO:0071108) | 2.36642238 |
| 188 | B cell receptor signaling pathway (GO:0050853) | 2.36305826 |
| 189 | DNA damage induced protein phosphorylation (GO:0006975) | 2.35706870 |
| 190 | double-strand break repair via homologous recombination (GO:0000724) | 2.35674359 |
| 191 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.35124076 |
| 192 | DNA methylation involved in gamete generation (GO:0043046) | 2.33903390 |
| 193 | tRNA methylation (GO:0030488) | 2.33622939 |
| 194 | cellular response to exogenous dsRNA (GO:0071360) | 2.32802664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.28736048 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.50204017 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.41585804 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.37215425 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.78255074 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.77304723 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.75515062 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.75105244 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.94945296 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.93995096 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.77649608 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.67552687 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.67548357 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.51419172 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.51057949 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.48186549 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.47927581 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.45877338 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.39127202 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.38954947 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.28459771 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.24821205 |
| 23 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.15923214 |
| 24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.15859001 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.13599441 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.12492413 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.04063456 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03032889 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.01420709 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.00704974 |
| 31 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.00188120 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.00103318 |
| 33 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.93855259 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.92339573 |
| 35 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.92285773 |
| 36 | * MYB_26560356_Chip-Seq_TH2_Human | 1.90574424 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87199118 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84962866 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.82785066 |
| 40 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.78737158 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.77124369 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.69609181 |
| 43 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64838934 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60844423 |
| 45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.59006997 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.54869963 |
| 47 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.53681474 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53529934 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.53366272 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.53182370 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51636572 |
| 52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.51611823 |
| 53 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.50690544 |
| 54 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50647407 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.50525046 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49836919 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47226005 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.45780236 |
| 59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.45668610 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.45382853 |
| 61 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.44986597 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43919203 |
| 63 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.41829485 |
| 64 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.41248365 |
| 65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.39284833 |
| 66 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38191149 |
| 67 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37552435 |
| 68 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37363554 |
| 69 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.37136447 |
| 70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37028818 |
| 71 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35938809 |
| 72 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33320788 |
| 73 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.33264749 |
| 74 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.32951220 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31129680 |
| 76 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.30073414 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.29977012 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28061633 |
| 79 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27955821 |
| 80 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.27275574 |
| 81 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26747811 |
| 82 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.26355326 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26231127 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25615784 |
| 85 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.25408454 |
| 86 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.24114476 |
| 87 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.23918190 |
| 88 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.22704146 |
| 89 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20611824 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.19032524 |
| 91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.18171584 |
| 92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18104119 |
| 93 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17579634 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17444271 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17313803 |
| 96 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15841836 |
| 97 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15528233 |
| 98 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15132194 |
| 99 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.14984345 |
| 100 | MAF_26560356_Chip-Seq_TH1_Human | 1.14471250 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14165381 |
| 102 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13129268 |
| 103 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.12397532 |
| 104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10852648 |
| 105 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10347801 |
| 106 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.10311647 |
| 107 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10196882 |
| 108 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09737711 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07051545 |
| 110 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.06452779 |
| 111 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05799105 |
| 112 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05102230 |
| 113 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.05012905 |
| 114 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04697399 |
| 115 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03278174 |
| 116 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02532156 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02200438 |
| 118 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02171840 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01237505 |
| 120 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.01198130 |
| 121 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01118209 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00568312 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00568312 |
| 124 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00234823 |
| 125 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99587079 |
| 126 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.99326268 |
| 127 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99148665 |
| 128 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98500239 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98015729 |
| 130 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.97867455 |
| 131 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97502632 |
| 132 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.96471453 |
| 133 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 0.96446606 |
| 134 | SPI1_23127762_ChIP-Seq_K562_Human | 0.96065031 |
| 135 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95695408 |
| 136 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.95542467 |
| 137 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.95174297 |
| 138 | P300_27268052_Chip-Seq_Bcells_Human | 0.94189477 |
| 139 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93735096 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93707488 |
| 141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93659141 |
| 142 | ERA_21632823_ChIP-Seq_H3396_Human | 0.92916317 |
| 143 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92738513 |
| 144 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.92585883 |
| 145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.92261476 |
| 146 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91964513 |
| 147 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.91000227 |
| 148 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.90104640 |
| 149 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.89936470 |
| 150 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.89688650 |
| 151 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89679945 |
| 152 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89188837 |
| 153 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89094550 |
| 154 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.88852166 |
| 155 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88610261 |
| 156 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87886557 |
| 157 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87165907 |
| 158 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86489717 |
| 159 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.86454049 |
| 160 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.86178393 |
| 161 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.85805195 |
| 162 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.85715807 |
| 163 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84215872 |
| 164 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.84110314 |
| 165 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.84051733 |
| 166 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83613591 |
| 167 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83258146 |
| 168 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.83089421 |
| 169 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.81777180 |
| 170 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81643544 |
| 171 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.80510012 |
| 172 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.80339067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.20666749 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 4.36571398 |
| 3 | MP0005365_abnormal_bile_salt | 4.32271868 |
| 4 | MP0005360_urolithiasis | 4.17609050 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.03114642 |
| 6 | MP0003252_abnormal_bile_duct | 2.80692191 |
| 7 | MP0002163_abnormal_gland_morphology | 2.55737498 |
| 8 | MP0003195_calcinosis | 2.44067296 |
| 9 | MP0005670_abnormal_white_adipose | 2.40526038 |
| 10 | MP0005379_endocrine/exocrine_gland_phen | 2.40058359 |
| 11 | MP0003787_abnormal_imprinting | 2.39866643 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.30133768 |
| 13 | MP0009697_abnormal_copulation | 2.29542964 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.27073663 |
| 15 | MP0004043_abnormal_pH_regulation | 2.22512188 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.10240712 |
| 17 | MP0008877_abnormal_DNA_methylation | 2.08611229 |
| 18 | MP0003724_increased_susceptibility_to | 1.99130358 |
| 19 | MP0005332_abnormal_amino_acid | 1.95045965 |
| 20 | MP0000372_irregular_coat_pigmentation | 1.94280376 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 1.93106511 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.92206299 |
| 23 | MP0008057_abnormal_DNA_replication | 1.86679670 |
| 24 | MP0001666_abnormal_nutrient_absorption | 1.84560386 |
| 25 | MP0002009_preneoplasia | 1.77075030 |
| 26 | MP0000538_abnormal_urinary_bladder | 1.75511671 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.73870889 |
| 28 | MP0005083_abnormal_biliary_tract | 1.73775953 |
| 29 | MP0005310_abnormal_salivary_gland | 1.71215884 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.70990230 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.61251218 |
| 32 | MP0002398_abnormal_bone_marrow | 1.58117802 |
| 33 | MP0003786_premature_aging | 1.57692432 |
| 34 | MP0000609_abnormal_liver_physiology | 1.57193387 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.57084049 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56928086 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.54640694 |
| 38 | MP0004381_abnormal_hair_follicle | 1.54261507 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.54035597 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.51662430 |
| 41 | MP0003868_abnormal_feces_composition | 1.50541256 |
| 42 | MP0009785_altered_susceptibility_to | 1.49687102 |
| 43 | MP0002928_abnormal_bile_duct | 1.49568099 |
| 44 | MP0004084_abnormal_cardiac_muscle | 1.48729590 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.47770583 |
| 46 | MP0004215_abnormal_myocardial_fiber | 1.47543684 |
| 47 | MP0009764_decreased_sensitivity_to | 1.43154528 |
| 48 | MP0002722_abnormal_immune_system | 1.43070001 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.39679095 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.38909310 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.37870035 |
| 52 | MP0005451_abnormal_body_composition | 1.37218570 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.36707585 |
| 54 | MP0003866_abnormal_defecation | 1.35696594 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 1.35416292 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.35078180 |
| 57 | MP0001764_abnormal_homeostasis | 1.33014699 |
| 58 | MP0003186_abnormal_redox_activity | 1.32429371 |
| 59 | MP0002419_abnormal_innate_immunity | 1.32030106 |
| 60 | MP0004147_increased_porphyrin_level | 1.31691965 |
| 61 | MP0001986_abnormal_taste_sensitivity | 1.31107166 |
| 62 | MP0008469_abnormal_protein_level | 1.29259685 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.28983209 |
| 64 | MP0005025_abnormal_response_to | 1.28973854 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.28604319 |
| 66 | MP0002254_reproductive_system_inflammat | 1.27453981 |
| 67 | MP0008961_abnormal_basal_metabolism | 1.26491895 |
| 68 | MP0005387_immune_system_phenotype | 1.26232764 |
| 69 | MP0001790_abnormal_immune_system | 1.26232764 |
| 70 | MP0004036_abnormal_muscle_relaxation | 1.24568421 |
| 71 | MP0000685_abnormal_immune_system | 1.24168517 |
| 72 | MP0004019_abnormal_vitamin_homeostasis | 1.23630577 |
| 73 | MP0003011_delayed_dark_adaptation | 1.22872400 |
| 74 | MP0002693_abnormal_pancreas_physiology | 1.22586562 |
| 75 | MP0004233_abnormal_muscle_weight | 1.22586549 |
| 76 | MP0008058_abnormal_DNA_repair | 1.22279540 |
| 77 | MP0002876_abnormal_thyroid_physiology | 1.22030324 |
| 78 | MP0001853_heart_inflammation | 1.22020469 |
| 79 | MP0001800_abnormal_humoral_immune | 1.19965355 |
| 80 | MP0003300_gastrointestinal_ulcer | 1.19175947 |
| 81 | MP0002429_abnormal_blood_cell | 1.17940637 |
| 82 | MP0004130_abnormal_muscle_cell | 1.15478499 |
| 83 | MP0000427_abnormal_hair_cycle | 1.13792018 |
| 84 | MP0009763_increased_sensitivity_to | 1.12409437 |
| 85 | MP0001873_stomach_inflammation | 1.09496432 |
| 86 | MP0003646_muscle_fatigue | 1.08974300 |
| 87 | MP0009840_abnormal_foam_cell | 1.08308386 |
| 88 | MP0003045_fibrosis | 1.08225195 |
| 89 | MP0003693_abnormal_embryo_hatching | 1.07785446 |
| 90 | MP0005671_abnormal_response_to | 1.07684333 |
| 91 | MP0002405_respiratory_system_inflammati | 1.07282654 |
| 92 | MP0002723_abnormal_immune_serum | 1.06080393 |
| 93 | MP0005330_cardiomyopathy | 1.05177628 |
| 94 | MP0002971_abnormal_brown_adipose | 1.03044285 |
| 95 | MP0005000_abnormal_immune_tolerance | 1.00588093 |
| 96 | MP0002909_abnormal_adrenal_gland | 0.99310996 |
| 97 | MP0003436_decreased_susceptibility_to | 0.98835393 |
| 98 | MP0003763_abnormal_thymus_physiology | 0.98705308 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.98430432 |
| 100 | MP0002452_abnormal_antigen_presenting | 0.98179669 |
| 101 | MP0005266_abnormal_metabolism | 0.97439754 |
| 102 | MP0002166_altered_tumor_susceptibility | 0.97254592 |
| 103 | MP0002972_abnormal_cardiac_muscle | 0.96775506 |
| 104 | MP0005408_hypopigmentation | 0.95978146 |
| 105 | MP0002277_abnormal_respiratory_mucosa | 0.95661791 |
| 106 | MP0008775_abnormal_heart_ventricle | 0.95186519 |
| 107 | MP0010094_abnormal_chromosome_stability | 0.92763370 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.92470231 |
| 109 | MP0003828_pulmonary_edema | 0.91977301 |
| 110 | MP0010155_abnormal_intestine_physiology | 0.91823884 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.91578314 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.91450345 |
| 113 | MP0004484_altered_response_of | 0.91393301 |
| 114 | MP0000569_abnormal_digit_pigmentation | 0.90931426 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.90387073 |
| 116 | MP0005535_abnormal_body_temperature | 0.88040482 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.87774339 |
| 118 | MP0004782_abnormal_surfactant_physiolog | 0.87180729 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.86776244 |
| 120 | MP0008872_abnormal_physiological_respon | 0.86718334 |
| 121 | MP0001879_abnormal_lymphatic_vessel | 0.86548611 |
| 122 | MP0005334_abnormal_fat_pad | 0.86129815 |
| 123 | MP0002420_abnormal_adaptive_immunity | 0.86058503 |
| 124 | MP0001819_abnormal_immune_cell | 0.85445094 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.83549708 |
| 126 | MP0005647_abnormal_sex_gland | 0.82960431 |
| 127 | MP0002019_abnormal_tumor_incidence | 0.81501805 |
| 128 | MP0000749_muscle_degeneration | 0.81253900 |
| 129 | MP0000598_abnormal_liver_morphology | 0.80011979 |
| 130 | MP0008995_early_reproductive_senescence | 0.79199893 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.78306846 |
| 132 | MP0000013_abnormal_adipose_tissue | 0.77734521 |
| 133 | MP0005075_abnormal_melanosome_morpholog | 0.77066673 |
| 134 | MP0005220_abnormal_exocrine_pancreas | 0.76741779 |
| 135 | MP0001544_abnormal_cardiovascular_syste | 0.76133683 |
| 136 | MP0005385_cardiovascular_system_phenoty | 0.76133683 |
| 137 | MP0003111_abnormal_nucleus_morphology | 0.76073696 |
| 138 | MP0005636_abnormal_mineral_homeostasis | 0.75018545 |
| 139 | MP0000371_diluted_coat_color | 0.74227920 |
| 140 | MP0002970_abnormal_white_adipose | 0.73699213 |
| 141 | MP0001756_abnormal_urination | 0.72910655 |
| 142 | MP0001919_abnormal_reproductive_system | 0.70539276 |
| 143 | MP0006035_abnormal_mitochondrial_morpho | 0.70441221 |
| 144 | MP0000470_abnormal_stomach_morphology | 0.70290479 |
| 145 | MP0000465_gastrointestinal_hemorrhage | 0.69495037 |
| 146 | MP0002006_tumorigenesis | 0.68930189 |
| 147 | MP0004947_skin_inflammation | 0.68532732 |
| 148 | MP0001944_abnormal_pancreas_morphology | 0.68510372 |
| 149 | MP0001270_distended_abdomen | 0.67405560 |
| 150 | MP0000716_abnormal_immune_system | 0.66767285 |
| 151 | MP0009765_abnormal_xenobiotic_induced | 0.62993413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Generalized aminoaciduria (HP:0002909) | 4.68345313 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 4.32555842 |
| 3 | Joint hemorrhage (HP:0005261) | 4.26507190 |
| 4 | Hypoglycemic coma (HP:0001325) | 4.14881993 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.05816614 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.97018882 |
| 7 | Renal cortical cysts (HP:0000803) | 3.95693817 |
| 8 | Pancreatic cysts (HP:0001737) | 3.89438847 |
| 9 | Pancreatic fibrosis (HP:0100732) | 3.87038451 |
| 10 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.69737862 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.53727240 |
| 12 | Abnormality of T cell physiology (HP:0011840) | 3.47660226 |
| 13 | Severe muscular hypotonia (HP:0006829) | 3.38483186 |
| 14 | Hyperammonemia (HP:0001987) | 3.33797928 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.33639486 |
| 16 | Vascular calcification (HP:0004934) | 3.31754837 |
| 17 | Ketosis (HP:0001946) | 3.29970295 |
| 18 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.20393098 |
| 19 | Dicarboxylic aciduria (HP:0003215) | 3.20393098 |
| 20 | Type II lissencephaly (HP:0007260) | 3.17553380 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.16764131 |
| 22 | Progressive muscle weakness (HP:0003323) | 3.12792399 |
| 23 | Ketoacidosis (HP:0001993) | 3.10761342 |
| 24 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.08727263 |
| 25 | Hypothermia (HP:0002045) | 3.07540806 |
| 26 | Abnormality of midbrain morphology (HP:0002418) | 3.05741306 |
| 27 | Molar tooth sign on MRI (HP:0002419) | 3.05741306 |
| 28 | Deep venous thrombosis (HP:0002625) | 3.05361095 |
| 29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.00349840 |
| 30 | Cerebellar dysplasia (HP:0007033) | 2.97567156 |
| 31 | Xanthomatosis (HP:0000991) | 2.95362220 |
| 32 | Cardiovascular calcification (HP:0011915) | 2.94955883 |
| 33 | Abnormality of T cells (HP:0002843) | 2.94491075 |
| 34 | Hyperglycinuria (HP:0003108) | 2.86322791 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.84568218 |
| 36 | Hepatic necrosis (HP:0002605) | 2.83184287 |
| 37 | Hypoglycemic seizures (HP:0002173) | 2.82660838 |
| 38 | Hypobetalipoproteinemia (HP:0003563) | 2.82170464 |
| 39 | Hyperlipoproteinemia (HP:0010980) | 2.75550209 |
| 40 | Myoglobinuria (HP:0002913) | 2.71363173 |
| 41 | Abnormality of methionine metabolism (HP:0010901) | 2.69138625 |
| 42 | Eczematoid dermatitis (HP:0000976) | 2.68293843 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.65636223 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 2.65636223 |
| 45 | Medial flaring of the eyebrow (HP:0010747) | 2.64284227 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 2.63054391 |
| 47 | Hyperbilirubinemia (HP:0002904) | 2.60616536 |
| 48 | Metabolic acidosis (HP:0001942) | 2.60603607 |
| 49 | Nephronophthisis (HP:0000090) | 2.59428380 |
| 50 | Recurrent fungal infections (HP:0002841) | 2.59313930 |
| 51 | Cerebral edema (HP:0002181) | 2.58787328 |
| 52 | Stomach cancer (HP:0012126) | 2.57902933 |
| 53 | Abnormality of the common coagulation pathway (HP:0010990) | 2.54731964 |
| 54 | Cerebral palsy (HP:0100021) | 2.49321965 |
| 55 | Severe combined immunodeficiency (HP:0004430) | 2.49134664 |
| 56 | Hypolipoproteinemia (HP:0010981) | 2.48243831 |
| 57 | Cystic liver disease (HP:0006706) | 2.47483956 |
| 58 | Tongue fasciculations (HP:0001308) | 2.47209001 |
| 59 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.46765374 |
| 60 | Hypoalphalipoproteinemia (HP:0003233) | 2.45329639 |
| 61 | Gingival bleeding (HP:0000225) | 2.43467371 |
| 62 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.42136640 |
| 63 | Fat malabsorption (HP:0002630) | 2.41846305 |
| 64 | Glycosuria (HP:0003076) | 2.41505052 |
| 65 | Abnormality of urine glucose concentration (HP:0011016) | 2.41505052 |
| 66 | Subaortic stenosis (HP:0001682) | 2.40924082 |
| 67 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.40924082 |
| 68 | Abnormality of the renal medulla (HP:0100957) | 2.36860854 |
| 69 | Tinnitus (HP:0000360) | 2.36117979 |
| 70 | Muscle fibrillation (HP:0010546) | 2.34396657 |
| 71 | Epidermoid cyst (HP:0200040) | 2.34104273 |
| 72 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.33661568 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.32726881 |
| 74 | IgG deficiency (HP:0004315) | 2.31872888 |
| 75 | Recurrent abscess formation (HP:0002722) | 2.31643929 |
| 76 | Complement deficiency (HP:0004431) | 2.31321125 |
| 77 | Palpitations (HP:0001962) | 2.31237128 |
| 78 | Ventricular tachycardia (HP:0004756) | 2.30868188 |
| 79 | Proximal tubulopathy (HP:0000114) | 2.30801473 |
| 80 | Lipoatrophy (HP:0100578) | 2.28838195 |
| 81 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.28525687 |
| 82 | Pachygyria (HP:0001302) | 2.28232459 |
| 83 | Asplenia (HP:0001746) | 2.26786053 |
| 84 | Pustule (HP:0200039) | 2.24437480 |
| 85 | Cheilitis (HP:0100825) | 2.22244328 |
| 86 | J-shaped sella turcica (HP:0002680) | 2.22233149 |
| 87 | Lethargy (HP:0001254) | 2.20817404 |
| 88 | Abnormality of purine metabolism (HP:0004352) | 2.20580493 |
| 89 | Atrial fibrillation (HP:0005110) | 2.19436501 |
| 90 | Elevated hepatic transaminases (HP:0002910) | 2.18707970 |
| 91 | Congenital stationary night blindness (HP:0007642) | 2.18581379 |
| 92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17043617 |
| 93 | Hypoplasia of the pons (HP:0012110) | 2.16700581 |
| 94 | Rhabdomyolysis (HP:0003201) | 2.15710310 |
| 95 | Recurrent cutaneous fungal infections (HP:0011370) | 2.15231142 |
| 96 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.15231142 |
| 97 | IgM deficiency (HP:0002850) | 2.14927547 |
| 98 | Abnormality of serum amino acid levels (HP:0003112) | 2.14274165 |
| 99 | Abnormality of nucleobase metabolism (HP:0010932) | 2.13925185 |
| 100 | Recurrent bacterial skin infections (HP:0005406) | 2.13465394 |
| 101 | Pancreatitis (HP:0001733) | 2.12908140 |
| 102 | Prolonged bleeding time (HP:0003010) | 2.12339400 |
| 103 | Abnormality of the renal cortex (HP:0011035) | 2.11433234 |
| 104 | Symptomatic seizures (HP:0011145) | 2.11030043 |
| 105 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.10959161 |
| 106 | Abnormality of alanine metabolism (HP:0010916) | 2.10959161 |
| 107 | Hyperalaninemia (HP:0003348) | 2.10959161 |
| 108 | Abnormality of T cell number (HP:0011839) | 2.08593776 |
| 109 | Increased muscle lipid content (HP:0009058) | 2.08560062 |
| 110 | Neoplasm of the adrenal cortex (HP:0100641) | 2.08410223 |
| 111 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07325996 |
| 112 | Menorrhagia (HP:0000132) | 2.05774135 |
| 113 | Chronic otitis media (HP:0000389) | 2.05539759 |
| 114 | Growth hormone excess (HP:0000845) | 2.04610006 |
| 115 | T lymphocytopenia (HP:0005403) | 2.03926922 |
| 116 | Autoimmune hemolytic anemia (HP:0001890) | 2.03747078 |
| 117 | Disproportionate short-trunk short stature (HP:0003521) | 2.03410121 |
| 118 | Nausea (HP:0002018) | 2.03304260 |
| 119 | Hyperglycinemia (HP:0002154) | 2.02492939 |
| 120 | Abnormality of the pons (HP:0007361) | 2.02203895 |
| 121 | Hepatocellular necrosis (HP:0001404) | 2.01383334 |
| 122 | Chronic diarrhea (HP:0002028) | 2.00746219 |
| 123 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.00614571 |
| 124 | Right ventricular cardiomyopathy (HP:0011663) | 1.97514629 |
| 125 | Increased serum lactate (HP:0002151) | 1.96580911 |
| 126 | Lissencephaly (HP:0001339) | 1.96468432 |
| 127 | Hypoplasia of the thymus (HP:0000778) | 1.95110725 |
| 128 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94907050 |
| 129 | Hypercholesterolemia (HP:0003124) | 1.94339594 |
| 130 | Tubular atrophy (HP:0000092) | 1.93897696 |
| 131 | Lactic acidosis (HP:0003128) | 1.91956353 |
| 132 | Abnormality of DNA repair (HP:0003254) | 1.90862424 |
| 133 | Epistaxis (HP:0000421) | 1.90480075 |
| 134 | Acute encephalopathy (HP:0006846) | 1.90245686 |
| 135 | Bone cyst (HP:0012062) | 1.88971243 |
| 136 | High pitched voice (HP:0001620) | 1.88430992 |
| 137 | Primary atrial arrhythmia (HP:0001692) | 1.87623872 |
| 138 | Dilated cardiomyopathy (HP:0001644) | 1.87533185 |
| 139 | Hepatocellular carcinoma (HP:0001402) | 1.86502158 |
| 140 | Exercise-induced myalgia (HP:0003738) | 1.86332826 |
| 141 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.86256018 |
| 142 | Large for gestational age (HP:0001520) | 1.84693957 |
| 143 | Asymmetric septal hypertrophy (HP:0001670) | 1.84612884 |
| 144 | Myocardial infarction (HP:0001658) | 1.83937774 |
| 145 | Vomiting (HP:0002013) | 1.83908464 |
| 146 | Furrowed tongue (HP:0000221) | 1.83589408 |
| 147 | Sudden death (HP:0001699) | 1.83477843 |
| 148 | True hermaphroditism (HP:0010459) | 1.83402654 |
| 149 | Stomatitis (HP:0010280) | 1.83261727 |
| 150 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82680704 |
| 151 | Hyperventilation (HP:0002883) | 1.81508383 |
| 152 | Steatorrhea (HP:0002570) | 1.81501541 |
| 153 | Supraventricular tachycardia (HP:0004755) | 1.80435145 |
| 154 | Attenuation of retinal blood vessels (HP:0007843) | 1.80378792 |
| 155 | Agammaglobulinemia (HP:0004432) | 1.78549464 |
| 156 | Recurrent viral infections (HP:0004429) | 1.78155408 |
| 157 | Poor coordination (HP:0002370) | 1.77578484 |
| 158 | Clumsiness (HP:0002312) | 1.76746106 |
| 159 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.75486876 |
| 160 | Increased intramyocellular lipid droplets (HP:0012240) | 1.75044776 |
| 161 | Microretrognathia (HP:0000308) | 1.74905354 |
| 162 | Dysautonomia (HP:0002459) | 1.74785002 |
| 163 | Reduced antithrombin III activity (HP:0001976) | 1.74191245 |
| 164 | Intellectual disability, progressive (HP:0006887) | 1.74015756 |
| 165 | Inflammation of the large intestine (HP:0002037) | 1.73141197 |
| 166 | Decreased circulating renin level (HP:0003351) | 1.72108393 |
| 167 | Axonal loss (HP:0003447) | 1.71702966 |
| 168 | Colitis (HP:0002583) | 1.71686695 |
| 169 | Supraventricular arrhythmia (HP:0005115) | 1.71532032 |
| 170 | Albinism (HP:0001022) | 1.67551533 |
| 171 | Congenital primary aphakia (HP:0007707) | 1.66971157 |
| 172 | Nephrogenic diabetes insipidus (HP:0009806) | 1.64998723 |
| 173 | Abnormality of chromosome stability (HP:0003220) | 1.63233830 |
| 174 | Protruding tongue (HP:0010808) | 1.63233201 |
| 175 | Neuroendocrine neoplasm (HP:0100634) | 1.62677188 |
| 176 | Hyperkalemia (HP:0002153) | 1.62223271 |
| 177 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.62071237 |
| 178 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.60997845 |
| 179 | Encephalitis (HP:0002383) | 1.60760194 |
| 180 | Abnormal drinking behavior (HP:0030082) | 1.59588696 |
| 181 | Polydipsia (HP:0001959) | 1.59588696 |
| 182 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.58414267 |
| 183 | Progressive inability to walk (HP:0002505) | 1.57468532 |
| 184 | Heterotopia (HP:0002282) | 1.56540154 |
| 185 | Chromsome breakage (HP:0040012) | 1.56354714 |
| 186 | Increased CSF lactate (HP:0002490) | 1.56037906 |
| 187 | Papilloma (HP:0012740) | 1.54625294 |
| 188 | Verrucae (HP:0200043) | 1.54625294 |
| 189 | Anorexia (HP:0002039) | 1.53668366 |
| 190 | Congenital hepatic fibrosis (HP:0002612) | 1.52769425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BMPR1B | 3.38410103 |
| 2 | BCKDK | 3.36919338 |
| 3 | INSRR | 3.08007469 |
| 4 | FRK | 2.50935320 |
| 5 | FLT3 | 2.45128045 |
| 6 | WNK4 | 2.40252952 |
| 7 | TXK | 2.27833871 |
| 8 | TGFBR2 | 2.22945560 |
| 9 | MYLK | 2.20341172 |
| 10 | MAP3K14 | 2.14343482 |
| 11 | TEC | 2.11398239 |
| 12 | LATS1 | 2.03495245 |
| 13 | IRAK1 | 2.03456522 |
| 14 | LMTK2 | 1.99952785 |
| 15 | IRAK3 | 1.96930517 |
| 16 | MAP4K1 | 1.89762772 |
| 17 | TAOK3 | 1.87084484 |
| 18 | KIT | 1.86722397 |
| 19 | ZAK | 1.84717997 |
| 20 | TNK2 | 1.84541011 |
| 21 | MAPKAPK3 | 1.78060657 |
| 22 | TYK2 | 1.74848285 |
| 23 | NEK9 | 1.72196770 |
| 24 | GRK6 | 1.69283043 |
| 25 | MAP3K7 | 1.67927872 |
| 26 | MAPK7 | 1.64007915 |
| 27 | MUSK | 1.63783323 |
| 28 | JAK1 | 1.60728921 |
| 29 | IRAK2 | 1.58306479 |
| 30 | PIK3CG | 1.56986317 |
| 31 | GRK7 | 1.56784833 |
| 32 | SIK1 | 1.46894236 |
| 33 | TIE1 | 1.43864758 |
| 34 | PHKG1 | 1.42857526 |
| 35 | PHKG2 | 1.42857526 |
| 36 | BTK | 1.41597544 |
| 37 | ACVR1B | 1.33323678 |
| 38 | OBSCN | 1.32684305 |
| 39 | CSF1R | 1.32288498 |
| 40 | IRAK4 | 1.32146586 |
| 41 | MAP2K6 | 1.31913870 |
| 42 | EEF2K | 1.29993916 |
| 43 | PLK4 | 1.29268506 |
| 44 | ERN1 | 1.28041160 |
| 45 | FGFR4 | 1.25411752 |
| 46 | MAP3K3 | 1.23331755 |
| 47 | TBK1 | 1.20862499 |
| 48 | TLK1 | 1.19390669 |
| 49 | EIF2AK2 | 1.19284328 |
| 50 | IKBKB | 1.18915118 |
| 51 | PIK3CA | 1.15873463 |
| 52 | TRIB3 | 1.12724871 |
| 53 | TRPM7 | 1.10625181 |
| 54 | JAK3 | 1.10565174 |
| 55 | EPHA3 | 1.09820242 |
| 56 | MAP3K13 | 1.09106962 |
| 57 | EPHB1 | 1.08326196 |
| 58 | MAP2K3 | 1.08274195 |
| 59 | PTK6 | 1.08106793 |
| 60 | TTN | 1.05963383 |
| 61 | MST4 | 1.03609697 |
| 62 | BLK | 1.01495959 |
| 63 | TAF1 | 1.00849810 |
| 64 | CASK | 0.99795090 |
| 65 | MARK3 | 0.99089408 |
| 66 | RIPK1 | 0.98136352 |
| 67 | MAPK11 | 0.97752788 |
| 68 | IKBKE | 0.97511589 |
| 69 | ITK | 0.96128554 |
| 70 | TGFBR1 | 0.95746894 |
| 71 | STK16 | 0.95251452 |
| 72 | STK24 | 0.94784307 |
| 73 | RIPK4 | 0.94668855 |
| 74 | JAK2 | 0.94386145 |
| 75 | SGK2 | 0.92673902 |
| 76 | GRK1 | 0.91935472 |
| 77 | SYK | 0.90515204 |
| 78 | PRKAA2 | 0.87935414 |
| 79 | NME2 | 0.87583732 |
| 80 | RPS6KB2 | 0.87224963 |
| 81 | STK39 | 0.86513874 |
| 82 | PRKG2 | 0.85217574 |
| 83 | NME1 | 0.84351519 |
| 84 | FES | 0.84149237 |
| 85 | HIPK2 | 0.83328621 |
| 86 | CAMK1 | 0.83310810 |
| 87 | MAP4K2 | 0.79985686 |
| 88 | CAMK4 | 0.77921484 |
| 89 | PKN2 | 0.76503375 |
| 90 | SIK2 | 0.76435683 |
| 91 | MAPK4 | 0.76236197 |
| 92 | ADRBK2 | 0.75759120 |
| 93 | RPS6KA6 | 0.75220654 |
| 94 | RPS6KL1 | 0.73134797 |
| 95 | RPS6KC1 | 0.73134797 |
| 96 | CAMK1D | 0.71847450 |
| 97 | LYN | 0.71384386 |
| 98 | SGK3 | 0.67982773 |
| 99 | MAPK12 | 0.67270425 |
| 100 | FGFR3 | 0.66787917 |
| 101 | PDK4 | 0.65574583 |
| 102 | PDK3 | 0.65574583 |
| 103 | PTK2B | 0.63815251 |
| 104 | NUAK1 | 0.63565169 |
| 105 | CDK8 | 0.63305704 |
| 106 | MAP3K2 | 0.62868895 |
| 107 | ZAP70 | 0.62157174 |
| 108 | PRKCQ | 0.61460041 |
| 109 | NLK | 0.61075528 |
| 110 | PINK1 | 0.60585027 |
| 111 | CCNB1 | 0.60470701 |
| 112 | HCK | 0.59666005 |
| 113 | PDK1 | 0.57226622 |
| 114 | MAP2K2 | 0.57082850 |
| 115 | MAPK15 | 0.57029995 |
| 116 | SMG1 | 0.56593740 |
| 117 | MAP2K7 | 0.56458015 |
| 118 | PKN1 | 0.56308787 |
| 119 | ATR | 0.56058309 |
| 120 | CHEK2 | 0.53114294 |
| 121 | STK3 | 0.52704928 |
| 122 | MAP2K1 | 0.51293756 |
| 123 | CHUK | 0.47851776 |
| 124 | WNK1 | 0.47724696 |
| 125 | LCK | 0.47634969 |
| 126 | RPS6KA2 | 0.47535288 |
| 127 | TAOK2 | 0.46521783 |
| 128 | CSK | 0.46242836 |
| 129 | NEK6 | 0.46191336 |
| 130 | MELK | 0.46061495 |
| 131 | CAMK2D | 0.44883631 |
| 132 | CAMKK2 | 0.44705603 |
| 133 | BRD4 | 0.43786990 |
| 134 | ILK | 0.43232875 |
| 135 | CDK4 | 0.42995569 |
| 136 | SIK3 | 0.42757378 |
| 137 | BMX | 0.42425462 |
| 138 | PRKCH | 0.42172982 |
| 139 | CDK7 | 0.41673296 |
| 140 | PRKCD | 0.41359122 |
| 141 | CLK1 | 0.40966152 |
| 142 | VRK2 | 0.40864812 |
| 143 | STK10 | 0.40805905 |
| 144 | PIM1 | 0.36931917 |
| 145 | YES1 | 0.36204760 |
| 146 | PRKD2 | 0.35991179 |
| 147 | MAPKAPK2 | 0.35430287 |
| 148 | PRKAA1 | 0.35147812 |
| 149 | VRK1 | 0.30283879 |
| 150 | ADRBK1 | 0.29160816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.38543116 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.18519506 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.09629896 |
| 4 | Homologous recombination_Homo sapiens_hsa03440 | 2.91307976 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.88218032 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.72614782 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63932957 |
| 8 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.52625604 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.45909415 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.44880955 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.44831050 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.36643748 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.32210488 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.22867329 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.20428023 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.18827864 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16156510 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.14626438 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.10745498 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.08746731 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.08522513 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05812154 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.00381349 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.99011620 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.87503187 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81078569 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80842177 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.80820579 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.75996421 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.71529699 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69461497 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.69158141 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.66404934 |
| 34 | RNA polymerase_Homo sapiens_hsa03020 | 1.66057333 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.65787952 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.65468106 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.64260474 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.60760154 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.56541013 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.52736975 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 1.52416222 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52290326 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51367474 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 1.44116676 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.43106934 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.37339273 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.36711882 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36070621 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29864645 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26795394 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.26736111 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24990384 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21256240 |
| 54 | Purine metabolism_Homo sapiens_hsa00230 | 1.21064412 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20955278 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19035100 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19029075 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18814682 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16392260 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16340016 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15836397 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09829529 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.09025768 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 1.01069242 |
| 65 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.99717279 |
| 66 | Basal transcription factors_Homo sapiens_hsa03022 | 0.99244896 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96639756 |
| 68 | DNA replication_Homo sapiens_hsa03030 | 0.95492140 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.90416079 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88119178 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88101352 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.86417990 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85316765 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83724653 |
| 75 | Mismatch repair_Homo sapiens_hsa03430 | 0.82016832 |
| 76 | RNA transport_Homo sapiens_hsa03013 | 0.81668078 |
| 77 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.77376483 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77214995 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76914840 |
| 80 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76865115 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73020277 |
| 82 | Asthma_Homo sapiens_hsa05310 | 0.71821761 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67112139 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66106128 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64627101 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64048231 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.63790896 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62494229 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.62177795 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61467408 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60754847 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60639678 |
| 93 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60511328 |
| 94 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59381097 |
| 95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.59069837 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58741926 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57760469 |
| 98 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57700754 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57635329 |
| 100 | Phototransduction_Homo sapiens_hsa04744 | 0.57293675 |
| 101 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57151924 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56830614 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56719255 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56606753 |
| 105 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56498712 |
| 106 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.56465153 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55267225 |
| 108 | Allograft rejection_Homo sapiens_hsa05330 | 0.54752676 |
| 109 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54062646 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53692600 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53291663 |
| 112 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51033251 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50683034 |
| 114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50274213 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48484043 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44614733 |
| 117 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44513068 |
| 118 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43086590 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.42958447 |
| 120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42194152 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41076529 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40675358 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.40661700 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.40621795 |
| 125 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40358555 |
| 126 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40065914 |
| 127 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39908547 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39383733 |
| 129 | Measles_Homo sapiens_hsa05162 | 0.39295366 |
| 130 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38177836 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.37697466 |
| 132 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36985465 |
| 133 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36270828 |
| 134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35612069 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34163214 |
| 136 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.33863468 |
| 137 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.32224884 |
| 138 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.31779103 |
| 139 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30972672 |
| 140 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.29991458 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29787532 |
| 142 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29237149 |
| 143 | Protein export_Homo sapiens_hsa03060 | 0.26567629 |
| 144 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22991985 |
| 145 | Malaria_Homo sapiens_hsa05144 | 0.22677995 |
| 146 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.21682812 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21256146 |
| 148 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.20177747 |
| 149 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19191325 |
| 150 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18228662 |
| 151 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.16785985 |
| 152 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.16783164 |
| 153 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.15515871 |
| 154 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.15273840 |
| 155 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.14934023 |

